首页> 外文OA文献 >Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score ( mCCS )

【2h】

Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score ( mCCS )

机译：新型预后评分的开发和验证预测转移结直肠癌患者的生存：转移结直肠癌评分（MCC）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
N. Marschner; M. Frank; W. Vach; E. Ladda; A. Karcher; S. Winter; M. Jänicke; T. Trarbach;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A prognostic indicator of survival in metastatic colorectal cancer patients in the era of molecular-targeted agents: The modified glasgow prognostic score [J] . DreanicJ., DhoogeM., BrezaultC., Oncology: International Journal of Cancer Research and Treatment . 2014,第1期

机译：分子靶向药物时代转移性大肠癌患者生存的预后指标：改良的格拉斯哥预后评分
2. The impact of the Glasgow Prognostic Score on survival in second-line chemotherapy for metastatic colorectal cancer patients with BRAF V600E mutation [J] . Seiichiro Mitani, Hiroya Taniguchi, Keiji Sugiyama, Therapeutic advances in medical oncology. . 2019,第11期

机译：格拉斯哥预后评分对BRAF V600E突变的转移性结直肠癌患者二线化疗生存率的影响
3. Prognostic factors and a survival score for patients with metastatic spinal cord compression from colorectal cancer. [J] . D Rades, S Douglas, S Huttenlocher, Strahlentherapie und Onkologie . 2012,第12期

机译：大肠癌转移性脊髓压迫患者的预后因素和生存评分。
4. Correlation between development of hypertension and efficacy in metastatic colorectal cancer patients treated with bevacizumab [C] . Horinouchi Y., Sakurada T., Nakamura T., European Association for Clinical Pharmacology and Therapeutics . 2011

机译：北伐单抗治疗转移性结直肠癌患者高血压与疗效的相关性
5. Predicting Survival Among Colorectal Cancer Patients: Development and Validation of Polygenic Survival Score [D] . Maawadh, Rawan Mohammed. 2020

机译：预测结肠直肠癌患者的生存：多基因生存率的发展和验证
6. Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancer [O] . Nobuhisa Matsuhashi, Takao Takahashi, Hironori Fujii, -1

机译：TAS-102联合贝伐单抗联合化疗在转移性结直肠癌抢救治疗中的单中心回顾性研究探讨改良的格拉斯哥预后评分在转移性结直肠癌抢救治疗中的预后价值
7. Development and validation of a prognostic score for overall survival integrating baseline metabolically active tumor volume measured by 18F-FDG PET/CT and clinical factors for metastatic colorectal cancer patients. [O] . Erwin Woff, Alain Hendlisz, Lisa Salvatore, 2019

机译：通过18F-FDG PET / CT和转移结直肠癌患者的临床因素测量基线整体存活的预后评分的开发和验证对基线的预后分数。

Development and validation of a novel prognostic score to predict survival in patients with metastatic colorectal cancer: the metastatic colorectal cancer score ( mCCS )

著录项

引文网络

相似文献

相关主题

期刊订阅